compounding semaglutide news today The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new compounded (Wegovy) weight-loss pill from the Semaglutide injections will no longer

SELECT Trial Semaglutide and Cardiovascular Outcomes (NEJM, 2023): 20% reduction in major adverse cardiovascular events with Wegovy in overweight/obesity

Not everyone needs to push to 12mg

Jowls: 34 months Chin: 34 months Around Eyes: 36 months Around Mouth: 34 months Barbie Botox: 36 months Forehead: 36 months Neck: 36 months The effects of Botox last several months, with maintenance treatments required to prolong the results

Anavar also appears to promote direct fat oxidation beyond what caloric deficit alone produces

Semaglutide needs to be injected once a week and it claims to reduce cravings for sweet and savory foods, to help with a positive mood